Phreesia’s (PHR) Market Outperform Rating Reiterated at JMP Securities

JMP Securities reissued their market outperform rating on shares of Phreesia (NYSE:PHR) in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have a $30.00 price objective on the stock.

A number of other equities analysts have also weighed in on PHR. Canaccord Genuity Group reiterated a “buy” rating and issued a $34.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. JPMorgan Chase & Co. increased their price target on shares of Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, September 9th. Royal Bank of Canada restated a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a research report on Friday, September 27th. DA Davidson reiterated a “buy” rating and set a $32.00 target price on shares of Phreesia in a research report on Thursday, September 5th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $29.00 price target on shares of Phreesia in a report on Tuesday. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.33.

Phreesia Price Performance

Shares of Phreesia stock opened at $24.55 on Tuesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. Phreesia has a 1 year low of $17.07 and a 1 year high of $29.16. The company’s fifty day moving average is $20.34 and its two-hundred day moving average is $21.78.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business’s revenue was up 16.6% on a year-over-year basis. During the same quarter last year, the company posted ($0.58) earnings per share. As a group, sell-side analysts forecast that Phreesia will post -1.22 earnings per share for the current fiscal year.

Insider Transactions at Phreesia

In other Phreesia news, SVP Amy Beth Vanduyn sold 25,447 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $20.93, for a total transaction of $532,605.71. Following the completion of the transaction, the senior vice president now directly owns 93,470 shares in the company, valued at approximately $1,956,327.10. This trade represents a 21.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 1,212 shares of the company’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total transaction of $25,488.36. Following the completion of the sale, the general counsel now directly owns 119,791 shares in the company, valued at $2,519,204.73. This trade represents a 1.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 53,569 shares of company stock valued at $1,123,014 in the last 90 days. 5.80% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Phreesia

A number of institutional investors have recently made changes to their positions in the stock. International Assets Investment Management LLC increased its position in Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after purchasing an additional 1,395 shares in the last quarter. nVerses Capital LLC boosted its stake in shares of Phreesia by 76.5% during the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock worth $64,000 after purchasing an additional 1,300 shares during the last quarter. Lombard Odier Asset Management USA Corp purchased a new stake in shares of Phreesia during the second quarter worth about $202,000. Point72 DIFC Ltd acquired a new position in shares of Phreesia in the second quarter valued at approximately $209,000. Finally, XTX Topco Ltd acquired a new position in shares of Phreesia in the third quarter valued at approximately $247,000. 92.10% of the stock is owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.